Povero, M. et al. 2024. [Cost per Responder Analysis of Filgotinib in Patients Suffering from Ulcerative Colitis]. Farmeconomia. Health economics and therapeutic pathways. 25, 1 (Mar. 2024). DOI:https://doi.org/10.7175/fe.v25i1.1554.